These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1570 related items for PubMed ID: 24905636
21. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells. Wang F, Li H, Yan XG, Zhou ZW, Yi ZG, He ZX, Pan ST, Yang YX, Wang ZZ, Zhang X, Yang T, Qiu JX, Zhou SF. Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225 [Abstract] [Full Text] [Related]
22. Curcumol Suppresses Breast Cancer Cell Metastasis by Inhibiting MMP-9 Via JNK1/2 and Akt-Dependent NF-κB Signaling Pathways. Ning L, Ma H, Jiang Z, Chen L, Li L, Chen Q, Qi H. Integr Cancer Ther; 2016 Jun; 15(2):216-25. PubMed ID: 27125675 [Abstract] [Full Text] [Related]
23. Isorhamnetin inhibited the proliferation and metastasis of androgen-independent prostate cancer cells by targeting the mitochondrion-dependent intrinsic apoptotic and PI3K/Akt/mTOR pathway. Cai F, Zhang Y, Li J, Huang S, Gao R. Biosci Rep; 2020 Mar 27; 40(3):. PubMed ID: 32039440 [Abstract] [Full Text] [Related]
24. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis. Zeng KW, Li N, Dong X, Ma ZZ, Jiang Y, Jin HW, Tu PF. Eur J Pharmacol; 2013 Aug 15; 714(1-3):261-73. PubMed ID: 23684542 [Abstract] [Full Text] [Related]
25. Tetrandrine suppresses metastatic phenotype of prostate cancer cells by regulating Akt/mTOR/MMP-9 signaling pathway. Kou B, Liu W, He W, Zhang Y, Zheng J, Yan Y, Zhang Y, Xu S, Wang H. Oncol Rep; 2016 May 15; 35(5):2880-6. PubMed ID: 26935264 [Abstract] [Full Text] [Related]
26. Naringin suppresses cell metastasis and the expression of matrix metalloproteinases (MMP-2 and MMP-9) via the inhibition of ERK-P38-JNK signaling pathway in human glioblastoma. Aroui S, Aouey B, Chtourou Y, Meunier AC, Fetoui H, Kenani A. Chem Biol Interact; 2016 Jan 25; 244():195-203. PubMed ID: 26721195 [Abstract] [Full Text] [Related]
27. Shikonin inhibits thyroid cancer cell growth and invasiveness through targeting major signaling pathways. Yang Q, Ji M, Guan H, Shi B, Hou P. J Clin Endocrinol Metab; 2013 Dec 25; 98(12):E1909-17. PubMed ID: 24106286 [Abstract] [Full Text] [Related]
28. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9. Sun LC, Luo J, Mackey LV, Fuselier JA, Coy DH. Cancer Lett; 2007 Feb 08; 246(1-2):157-66. PubMed ID: 16644105 [Abstract] [Full Text] [Related]
29. Shikonin suppresses the migratory ability of hepatocellular carcinoma cells. Wei PL, Tu CC, Chen CH, Ho YS, Wu CT, Su HY, Chen WY, Liu JJ, Chang YJ. J Agric Food Chem; 2013 Aug 28; 61(34):8191-7. PubMed ID: 23899086 [Abstract] [Full Text] [Related]
30. Fucoxanthin Activates Apoptosis via Inhibition of PI3K/Akt/mTOR Pathway and Suppresses Invasion and Migration by Restriction of p38-MMP-2/9 Pathway in Human Glioblastoma Cells. Liu Y, Zheng J, Zhang Y, Wang Z, Yang Y, Bai M, Dai Y. Neurochem Res; 2016 Oct 28; 41(10):2728-2751. PubMed ID: 27394418 [Abstract] [Full Text] [Related]
31. Caffeine induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-fos pathway and activation of p38 MAPK/c-jun pathway. Liu WH, Chang LS. J Cell Physiol; 2010 Sep 28; 224(3):775-85. PubMed ID: 20432471 [Abstract] [Full Text] [Related]
32. Inhibition of EGF-induced migration and invasion by sulfated polysaccharide of Sepiella maindroni ink via the suppression of EGFR/Akt/p38 MAPK/MMP-2 signaling pathway in KB cells. Jiang W, Tian W, Ijaz M, Wang F. Biomed Pharmacother; 2017 Nov 28; 95():95-102. PubMed ID: 28830011 [Abstract] [Full Text] [Related]
33. Antimetastatic effect and mechanism of ovatodiolide in MDA-MB-231 human breast cancer cells. Lin KL, Tsai PC, Hsieh CY, Chang LS, Lin SR. Chem Biol Interact; 2011 Nov 15; 194(2-3):148-58. PubMed ID: 22033475 [Abstract] [Full Text] [Related]
34. Pipoxolan inhibits CL1-5 lung cancer cells migration and invasion through inhibition of MMP-9 and MMP-2. Lee MM, Chen YY, Liu PY, Hsu S, Sheu MJ. Chem Biol Interact; 2015 Jul 05; 236():19-30. PubMed ID: 25899827 [Abstract] [Full Text] [Related]
35. Alpha-mangostin suppresses PC-3 human prostate carcinoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plasminogen expression through the JNK signaling pathway. Hung SH, Shen KH, Wu CH, Liu CL, Shih YW. J Agric Food Chem; 2009 Feb 25; 57(4):1291-8. PubMed ID: 19178296 [Abstract] [Full Text] [Related]
36. Piperine inhibits proliferation of human osteosarcoma cells via G2/M phase arrest and metastasis by suppressing MMP-2/-9 expression. Zhang J, Zhu X, Li H, Li B, Sun L, Xie T, Zhu T, Zhou H, Ye Z. Int Immunopharmacol; 2015 Jan 25; 24(1):50-8. PubMed ID: 25479727 [Abstract] [Full Text] [Related]
37. Cadmium induces matrix metalloproteinase-9 expression via ROS-dependent EGFR, NF-кB, and AP-1 pathways in human endothelial cells. Lian S, Xia Y, Khoi PN, Ung TT, Yoon HJ, Kim NH, Kim KK, Jung YD. Toxicology; 2015 Dec 02; 338():104-16. PubMed ID: 26514923 [Abstract] [Full Text] [Related]
38. Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells. Wang CC, Chiang YM, Sung SC, Hsu YL, Chang JK, Kuo PL. Cancer Lett; 2008 Jan 18; 259(1):82-98. PubMed ID: 18023967 [Abstract] [Full Text] [Related]
39. Anti-metastatic effect of rhodomyrtone from Rhodomyrtus tomentosa on human skin cancer cells. Tayeh M, Nilwarangoon S, Mahabusarakum W, Watanapokasin R. Int J Oncol; 2017 Mar 18; 50(3):1035-1043. PubMed ID: 28075447 [Abstract] [Full Text] [Related]
40. Inhibition of c-MYC with involvement of ERK/JNK/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells. Zhao Q, Assimopoulou AN, Klauck SM, Damianakos H, Chinou I, Kretschmer N, Rios JL, Papageorgiou VP, Bauer R, Efferth T. Oncotarget; 2015 Nov 17; 6(36):38934-51. PubMed ID: 26472107 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]